# The Efficacy and Safety of Chlorhexidine Gluconate Chip (PerioChip®) in Therapy of Peri-implantitis

> **NCT02080403** · PHASE3 · COMPLETED · sponsor: **Dexcel Pharma Technologies Ltd.** · enrollment: 290 (actual)

## Conditions studied

- Peri-Implantitis

## Interventions

- **DRUG:** 2.5 mg Chlorhexidine gluconate chip

## Key facts

- **NCT ID:** NCT02080403
- **Lead sponsor:** Dexcel Pharma Technologies Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2018-10
- **Final completion:** 2018-11
- **Target enrollment:** 290 (ACTUAL)
- **Last updated:** 2022-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02080403

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02080403, "The Efficacy and Safety of Chlorhexidine Gluconate Chip (PerioChip®) in Therapy of Peri-implantitis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02080403. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*